Neurotensin(8-13)
Neurotensin fragment 8-13
Arg-Arg-Pro-Tyr-Ile-Leu Amino Acids · MW: 830.99 Da
Amino Acids
Arg-Arg-Pro-Tyr-Ile-Leu
Molecular Weight
830.99 Da
Half-life
about 1-3 minutes
Research Score
4.0
Studies
78
Storage
Store lyophilized at -20°C, reconstituted at 2-8°C
What is Neurotensin(8-13)?
Neurotensin(8-13) is a shortened neurotensin fragment used as the basis for NTSR1-targeted imaging probes. Radiolabeled derivatives have been explored for pancreatic, prostate, and colorectal tumor imaging because they retain receptor recognition while remaining small and fast clearing.
Key Benefits & Mechanisms
NTSR1 targeting
small-peptide tracer design
fast imaging kinetics
Research Summary
Neurotensin-based radiotracers have been developed with 68Ga, 64Cu, and 18F for receptor-positive tumors. The 8-13 fragment is the classic minimal binding region used in many probe optimization programs.
Related Peptides
Bombesin
Bombesin (GRPR-targeting peptide scaffold)
Bombesin is a classic gastrin-releasing peptide receptor scaffold used in diagnostic tracer development. Radiolabeled bombesin analogs have been investigated for prostate, breast, and pancreatic cancer imaging because GRPR is frequently overexpressed in these tumors.
Diagnostic PeptidesProcalcitonin
Procalcitonin (PCT, calcitonin precursor fragment)
A 116-aa prohormone fragment that rises during systemic bacterial infection and sepsis. It is widely measured in serum or plasma to help distinguish bacterial from non-bacterial inflammation and to support antibiotic stewardship.
Diagnostic PeptidesAmyloid beta 1-42
Amyloid beta peptide 1-42 (Aβ1-42)
A 42-aa peptide derived from amyloid precursor protein and a core biomarker for Alzheimer-type amyloid pathology. In CSF and plasma testing, it is often interpreted together with Aβ1-40 using the Aβ42/40 ratio to improve diagnostic performance.
Diagnostic PeptidesAmyloid beta 1-40
Amyloid beta peptide 1-40 (Aβ1-40)
A 40-aa amyloid peptide that complements Aβ1-42 in diagnostic testing for Alzheimer's disease. The Aβ42/40 ratio is often more informative than either peptide alone for estimating amyloid burden.
Diagnostic Peptides